Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.
Sabine DanzingerYen Yen TanMargaretha RudasMarie-Theres KastnerSigrid WeingartshoferDaniela MuhrChristian F SingerPublished in: BMC cancer (2019)
Our data suggests that CLDN3, CK5, and CK14 in combination with ER, PR and HER2 are associated with BRCA1 mutation status.